The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for chronic lung disease bronchiectasis in the US. The regulator has set a ...

Established in 2018, the Johns Hopkins Center for Nontuberculous Mycobacteria and Bronchiectasis is dedicated to the specialized care of adult patients with suspected or confirmed nontuberculous ...

Portfolio management, financial planning, trustee, responsible entity and compliance services, executor services, investment administration and custody services.

The hallmark of CF is progressive, obstructive lung disease due to abnormal airway secretions, leading to chronic airway infection, excessive inflammation, bronchiectasis and parenchymal damage.2 Over ...

Here's a pretty strange Roblox game, where you play as a student in a classroom. Unlike in a real school, you can pay points to do absurd things like throw a toilet, scream at your teacher, break your ...